URGN Competitors & Alternatives
Compare UroGen Pharma Ltd with similar stocks in the same industry
Biotechnology
URGN
Main Stock$41.40
Tradestie Score
67
Market Cap
$824.20M
Revenue Growth
2.0%
Analyst Upside
+44.9%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$20.00
|
$2.18B | - | 65 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.08
|
$2.08B | - | 53 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.50
|
$2.02B | - | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.26
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.02
|
$1.97B | - | 52 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.96
|
$1.92B | - | 51 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$72.10
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$28.64
|
$1.90B | 21.5 | 42 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$30.42
|
$1.84B | - | 51 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.71
|
$1.81B | - | 50 | Compare |
More URGN Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry